Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.29 USD | -0.38% | -0.09% | +40.29% |
15/04 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
15/04 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.